Role of Toll-Like Receptor Signaling in the Pathogenesis of Graft-versus-Host Diseases
Open Access
- 11 August 2016
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (8) , 1288
Abstract
Graft-versus-host disease (GVHD) and infection are major complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and the leading causes of morbidity and mortality in HSCT patients. Recent work has demonstrated that the two complications are interdependent. GVHD occurs when allo-reactive donor T lymphocytes are activated by major histocompatibility antigens or minor histocompatibility antigens on host antigen-presenting cells (APCs), with the eventual attack of recipient tissues or organs. Activation of APCs is important for the priming of GVHD and is mediated by innate immune signaling pathways. Current evidence indicates that intestinal microbes and innate pattern-recognition receptors (PRRs) on host APCs, including both Toll-like receptors (TLRs) and nucleotide oligomerization domain (NOD)-like receptors (NLRs), are involved in the pathogenesis of GVHD. Patients undergoing chemotherapy and/or total body irradiation before allo-HSCT are susceptible to aggravated gastrointestinal epithelial cell damage and the subsequent translocation of bacterial components, followed by the release of endogenous dangerous molecules, termed pathogen-associated molecular patterns (PAMPs), which then activate the PRRs on host APCs to trigger local or systemic inflammatory responses that modulate T cell allo-reactivity against host tissues, which is equivalent to GVHD. In other words, infection can, to some extent, accelerate the progression of GVHD. Therefore, the intestinal flora’s PAMPs can interact with TLRs to activate and mature APCs, subsequently activate donor T cells with the release of pro-inflammatory cytokines, and eventually, induce GVHD. In the present article, we summarize the current perspectives on the understanding of different TLR signaling pathways and their involvement in the occurrence of GVHD.Keywords
Funding Information
- National Natural Science Foundation of China (81372249, 81300431)
- Science and Technology Planning Project of Guangdong Province, China (2016A020213005)
- Science and Technology Planning Project of Guangdong Province, China (2013B091500072)
- Project of Department of Education of Guangdong Province, China (2014GKXM029)
This publication has 57 references indexed in Scilit:
- Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associatedBone Marrow Transplantation, 2010
- Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethalityBlood, 2009
- Toll-like receptors and innate immunityBiochemical and Biophysical Research Communications, 2009
- Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9Bone Marrow Transplantation, 2009
- TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejectionBlood, 2008
- Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compoundJournal of Leukocyte Biology, 2007
- Surface Expression of Toll-Like Receptor 9 Is Upregulated on Intestinal Epithelial Cells in Response to Pathogenic Bacterial DNAInfection and Immunity, 2007
- Gut Toxicity During Hemopoietic Stem Cell Transplantation May Predict Acute Graft-Versus-Host Disease Severity in PatientsDigestive Diseases and Sciences, 2007
- Opposing effects of Toll-like receptor stimulation induce autoimmunity or toleranceTrends in Immunology, 2007
- Cox-2 Is Regulated by Toll-Like Receptor-4 (TLR4) Signaling: Role in Proliferation and Apoptosis in the IntestineGastroenterology, 2006